Home » Topics » BioWorld Science

BioWorld Science
RSS

Research on IL-38 mRNA expression in cancers supports Immunome's development of IMM-ONC-01

May 24, 2022

Anti-IL13RA1 eblasakimab reduces neuronal response to proinflammatory cytokines

May 24, 2022

PharmaCyte studies pancreatic cancer therapy to treat malignant ascites

May 24, 2022

Aptamer and PinotBio extend collaboration to develop Optimer-drug conjugates

May 24, 2022

KaliVir and Roche to collaborate on novel oncolytic vaccinia viruses

May 24, 2022

FDA grants orphan drug designation to DepYmed's DPM-1001 for Wilson disease

May 24, 2022

Salubris submits CTA in Europe for CTLA-4/IL-15 antibody fusion protein JK-08

May 24, 2022

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

May 24, 2022

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

May 24, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...